These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3742932

  • 1. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L, Nordin C, Otani K, Resul B, Scheinin M, Siwers B, Sjöqvist F.
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [Abstract] [Full Text] [Related]

  • 2. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
    Dahl-Puustinen ML, Perry TL, Dumont E, von Bahr C, Nordin C, Bertilsson L.
    Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
    [Abstract] [Full Text] [Related]

  • 3. Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion.
    Nordin C, Collste P, Otani K, Scheinin M.
    Methods Find Exp Clin Pharmacol; 1987 Oct; 9(10):691-6. PubMed ID: 2964548
    [Abstract] [Full Text] [Related]

  • 4. Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects.
    Nordin C, Bertilsson L, Otani K, Widmark A.
    Clin Pharmacol Ther; 1987 Jan; 41(1):97-102. PubMed ID: 3802713
    [Abstract] [Full Text] [Related]

  • 5. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C, Bertilsson L.
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [Abstract] [Full Text] [Related]

  • 6. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C, Bertilsson L, Siwers B.
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [Abstract] [Full Text] [Related]

  • 7. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.
    Pollock BG, Everett G, Perel JM.
    Neuropsychopharmacology; 1992 Jan; 6(1):1-10. PubMed ID: 1571065
    [Abstract] [Full Text] [Related]

  • 8. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC, Alexopoulos GS, Shamoian CA, Manley MW, Dhar AK, Kutt H.
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [Abstract] [Full Text] [Related]

  • 9. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C, Bertilsson L, Siwers B.
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [Abstract] [Full Text] [Related]

  • 10. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S, Lynn K, Rosser R, Braithwaite R.
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [Abstract] [Full Text] [Related]

  • 11. Isomers of 10-hydroxynortriptyline in geriatric depression.
    Young RC, Dhar AK, Kutt H, Alexopoulos GS.
    Ther Drug Monit; 1988 Sep; 10(2):164-7. PubMed ID: 3381232
    [Abstract] [Full Text] [Related]

  • 12. Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors.
    Nilvebrant L, Nordin C.
    Pharmacol Toxicol; 1991 Jan; 68(1):64-7. PubMed ID: 2008414
    [Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatography-mass spectrometry for the quantification of nortriptyline and 10-hydroxynortriptyline in plasma.
    Tybring G, Nordin J, Widén J.
    J Chromatogr B Biomed Sci Appl; 1998 Sep 25; 716(1-2):382-6. PubMed ID: 9824256
    [Abstract] [Full Text] [Related]

  • 14. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB, Linnet K.
    Hum Psychopharmacol; 2005 Mar 25; 20(2):149-53. PubMed ID: 15624117
    [Abstract] [Full Text] [Related]

  • 15. CSF/plasma ratio of 10-hydroxynortriptyline is influenced by sex and body height.
    Nordin C.
    Psychopharmacology (Berl); 1993 Mar 25; 113(2):222-4. PubMed ID: 7855185
    [Abstract] [Full Text] [Related]

  • 16. Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
    Otani K, Kaneko S, Bertilsson L.
    Pharmacol Toxicol; 1991 May 25; 68(5):380-3. PubMed ID: 1946183
    [Abstract] [Full Text] [Related]

  • 17. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L, Otani K, Dahl ML, Nordin C, Aberg-Wistedt A.
    Pharmacol Toxicol; 1991 Feb 25; 68(2):100-3. PubMed ID: 1852713
    [Abstract] [Full Text] [Related]

  • 18. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS, Cooper TB, Suckow RF, Lyness SA, Haugen C, Palmer R, Sloane RB.
    J Clin Psychopharmacol; 1990 Oct 25; 10(5):333-7. PubMed ID: 2258449
    [Abstract] [Full Text] [Related]

  • 19. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C, Bertilsson L, Dahl ML, Resul B, Toresson G, Sjöqvist F.
    Psychopharmacology (Berl); 1991 Oct 25; 103(3):287-90. PubMed ID: 2057534
    [Abstract] [Full Text] [Related]

  • 20. Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.
    Lukey BJ, Jones DR, Wright JH, Hurst HE.
    Ther Drug Monit; 1989 Oct 25; 11(3):221-7. PubMed ID: 2728080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.